Catalyst Wire Dossier Catalyst Wire Dossier

RESTFUL noninvasive peripheral nerve stimulation device

· Noctrix Health, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RESTFUL noninvasive peripheral nerve stimulation device, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study) [NA]

See pricing